Insight

Latest California Healthline Stories

People With Down Syndrome Are Living Longer, but the Health System Still Treats Many as Kids

The median life expectancy for a U.S. baby born with Down syndrome jumped from about four years in 1950 to 58 years in the 2010s. That’s largely because they no longer can be denied lifesaving care, including surgeries for heart defects. But now, aging adults with Down syndrome face a health system unprepared to care for them.

As Montana’s Mental Health Crisis Care Crumbles, Politicians Promise Aid

One of Montana’s largest mental health providers has ratcheted back services amid financial troubles, leaving a vacuum. State policymakers have promised more money to aid behavioral health care, but lasting change could be years out.

Watch: Rulings on Abortion Pill Have Far-Reaching Repercussions

Sarah Varney, a senior correspondent for KHN, joins Ali Rogin of PBS NewsHour to discuss the ruling by a federal judge in Texas that threatens nationwide access to the widely used abortion drug mifepristone, and a separate ruling in Washington state that reached the opposite conclusion.

Abortion Clinics in Conservative-Led States Face Increasing Legal Threats

Since the U.S. Supreme Court reversed federal protections for abortions, medical providers in conservative-led states have been fighting legal and political battles — as well as escalating threats from the anti-abortion movement.

The Big Squeeze: More Enrollees and Smaller Networks Plague Some ACA Plans

Despite record enrollment in health insurance plans under the Affordable Care Act, some consumers who bought coverage and agents who helped them do so have had a tough start to the new year: Many say it’s hard to find an in-network doctor or hospital.

Gov. Newsom Wanted California to Cut Ties With Walgreens. Then Federal Law Got in the Way.

Gov. Gavin Newsom declared that California would cut ties with Walgreens after the company said it would not distribute abortion pills in some states. But federal rules make it difficult for the state to unwind its Medicaid prescription drug agreement, which paid Walgreens $1.5 billion last year.